This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
4 Best Breakout Stocks to Buy Now for Superlative Returns
by Tirthankar Chakraborty
CymaBay Therapeutics (CBAY), RxSight (RXST), UWM (UWMC) & Remitly Global (RELY) have been selected as the breakout stocks for today.
CBAYPositive Net Change RELYPositive Net Change UWMCPositive Net Change RXSTNegative Net Change
biotechnology tech-stocks
5 Best Investment Opportunities Using Relative Price Strength
by Nilanjan Choudhury
PLYA, RS, TGLS, PARR and BWMX are five stocks with explosive relative price strength.
RSNegative Net Change TGLSPositive Net Change PARRPositive Net Change PLYAPositive Net Change BWMXNegative Net Change
consumer-discretionary energy oil-energy retail
3 Momentum Anomaly Picks as Markets Shake Off Banking Crisis
by Supriyo Bose
Arista (ANET), Allegro (ALGM) and Crocs (CROX) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
CROXNegative Net Change ANETNegative Net Change ALGMNegative Net Change
cloud-computing communications retail tech-stocks
Why Hold Strategy is Apt for Enterprise Products (EPD) Now
by Zacks Equity Research
Enterprise Products (EPD) has a stable business model and is not significantly exposed to the volatility in oil and gas prices.
EPDPositive Net Change VLOPositive Net Change SUNNegative Net Change MUSAPositive Net Change
oil-energy
Diamondback (FANG) Joins UN Program to Lower Methane Intensity
by Zacks Equity Research
Diamondback Energy (FANG) participates in the Oil and Gas Methane Partnership 2.0, which is the United Nations Environment Programme's flagship oil and gas reporting and mitigation program.
CVIPositive Net Change MUSAPositive Net Change FANGPositive Net Change PARRPositive Net Change
energy oil-energy
Jefferies (JEF) Q1 Earnings Beat Estimates on Lower Expenses
by Zacks Equity Research
A fall in expenses and better-than-expected capital markets performance support Jefferies' (JEF) fiscal Q1 earnings.
BACPositive Net Change JPMPositive Net Change JEFPositive Net Change
banking earnings finance
Simulations Plus (SLP) Joins SACF to Develop Anticancer Drugs
by Zacks Equity Research
Simulations Plus (SLP) will be working on the development of QSAR models by utilizing information available from both academic/patent literature and SACF to test effectiveness against MTHFD2.
SLPNegative Net Change CDNSNegative Net Change PEGAPositive Net Change ANETNegative Net Change
tech-stocks
Emeren (SOL) Q4 Revenues Miss Estimates, Earnings Up Y/Y
by Zacks Equity Research
Emeren's (SOL) Q4 adjusted net revenues of $40.8 million surge 79% year over year from $22.8 million.
SOLNegative Net Change FSLRNegative Net Change CSIQNegative Net Change ENPHNegative Net Change
earnings oil-energy
Raytheon (RTX) Wins $1.2B Deal for PATRIOT Missile System
by Zacks Equity Research
Raytheon (RTX) is going to supply fire units for PATRIOT Missile System.
LMTPositive Net Change NOCPositive Net Change GDPositive Net Change RTXPositive Net Change
aerospace
Here's Why Investors May Bet on Perion Network (PERI) Stock
by Zacks Equity Research
Perion's (PERI) performance is being driven by continued strength in Display Advertising and Search Advertising business segments.
CDNSNegative Net Change PERINegative Net Change PEGAPositive Net Change ANETNegative Net Change
tech-stocks
Petrobras (PBR) to Boost Oil Production Amid Climate Concerns
by Zacks Equity Research
Petrobras (PBR) plans to raise production to 2.7mb/d by 2025, despite climate concerns. It expects an increase in future oil demand.
PBRPositive Net Change NGLPositive Net Change ETNegative Net Change HLXNegative Net Change
energy oil-energy
DOW Launches Six Sustainable Products at in-cosmetics Global
by Zacks Equity Research
DOW personal care unveils six new products at in-cosmetics global 2023 to further speed up its ongoing transformation toward a sustainable portfolio.
STLDPositive Net Change DOWNegative Net Change ZEUSPositive Net Change LINNegative Net Change
basic-materials biotechnology
Air Products (APD) Seals NASA Deals to Supply Liquid Hydrogen
by Zacks Equity Research
Air Products (APD) secures more than $130 million in NASA contracts for liquid hydrogen supply.
APDPositive Net Change STLDPositive Net Change ZEUSPositive Net Change LINNegative Net Change
aerospace basic-materials
SL Green (SLG) Inks Lease With Palo Alto at One Madison Avenue
by Zacks Equity Research
SL Green (SLG) announces the signing of a long-term lease with Palo Alto Networks at One Madison Avenue, reflecting the decent demand for its high-quality and well-amenetized office properties.
SLGNegative Net Change TRNOPositive Net Change AREPositive Net Change SVCPositive Net Change
finance reit
Why Should You Hold Gibraltar Industries (ROCK) Stock Now
by Zacks Equity Research
The Three-Pillar strategy and strong renewable business prospects boost Gibraltar Industries' (ROCK) results in the quarters ahead amid challenges.
ROCKPositive Net Change NVRPositive Net Change STRLPositive Net Change TMHCPositive Net Change
construction
Unity (UNX) Down on Disappointing Results From Wet AMD Study
by Zacks Equity Research
Unity's (UBX) phase II ENVISION study on UBX1325 fails to meet the non-inferiority threshold compared to aflibercept through 24 weeks in the wet AMD study.
REGNPositive Net Change BAYRYNegative Net Change UBXNegative Net Change
biotechnology pharmaceuticals
Bristol Myers (BMY) Gets Approval of Psoriasis Drug in EU
by Zacks Equity Research
Bristol Myers' (BMY) Sotyktu gets approval from the European Commission to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.
BMYNegative Net Change NVONegative Net Change AMGNPositive Net Change LGNDNegative Net Change
biotechnology biotechs pharmaceuticals
GSK's Jemperli Effective Against First-Line Endometrial Cancer
by Zacks Equity Research
A late-stage study data shows that GSK's Jemperli reduced disease progression risk or death by 72% for treating adult patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer.
GSKNegative Net Change MRKPositive Net Change ANABNegative Net Change CERTPositive Net Change
biotechs medical pharmaceuticals
Lennar (LEN) to Make Low Profits in 2023 Amid Price Momentum
by Zacks Equity Research
Rising mortgage rates and affordability issues are potent headwinds for Lennar (LEN).
LENPositive Net Change URIPositive Net Change STRLPositive Net Change SKYPositive Net Change
construction home-builder
Lyft (LYFT) Announces New CEO, Co-founders to Step Down
by Zacks Equity Research
Lyft (LYFT) continues to struggle, as evidenced by the 12.9% year-to-date decline in its shares.
AMZNNegative Net Change MSFTNegative Net Change LYFTPositive Net Change UBERNegative Net Change
ride-hailing
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
by Zacks Equity Research
While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand and its pricing actions.
STLDPositive Net Change AUYPositive Net Change ZEUSPositive Net Change CCNegative Net Change
basic-materials
Astec (ASTE) Bets on Improving Demand Amid Cost Woes
by Zacks Equity Research
Astec (ASTE) will gain from solid demand in its markets and the launch of new products despite inflationary pressures.
ITWNegative Net Change OINegative Net Change ASTEPositive Net Change ALGNegative Net Change
industrial-products
Jounce (JNCE) Up 21% on Accepting Concentra's Buyout Offer
by Zacks Equity Research
Jounce Therapeutics (JNCE) is set to be acquired by Concentra Biosciences, spurning an all-share merger deal with British biotech firm Redx Pharma.
CRSPNegative Net Change JNCEPositive Net Change CERTPositive Net Change
medical
Comcast (CMCSA) Expanding Footprint in Oregon and Washington
by Zacks Equity Research
Comcast (CMCSA) announces expansion of Internet and support services in Oregon and Washington to reduce digital inequality and expand its footprint.
CMCSANegative Net Change NFLXNegative Net Change DISPositive Net Change CHTRPositive Net Change
consumer-discretionary
Dow (DOW) Shares Up 18% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
Dow (DOW) gains on firm demand in a number of end markets, strategic investments and its productivity initiatives.
STLDPositive Net Change DOWNegative Net Change AUYPositive Net Change ZEUSPositive Net Change
basic-materials